دورية أكاديمية
tPCS as a method for correcting cardiac arrhythmias after percutaneous transluminal coronary angioplasty with stenting in patients with myocardial infarction
| العنوان: | tPCS as a method for correcting cardiac arrhythmias after percutaneous transluminal coronary angioplasty with stenting in patients with myocardial infarction |
|---|---|
| المؤلفون: | A. Kh. Kade, E. A. Sorokina, S. A. Raff, A. I. Trofimenko, E. S. Zanina, А. Yu. Muratova |
| المصدر: | Инновационная медицина Кубани, Vol 0, Iss 3, Pp 29-36 (2022) |
| بيانات النشر: | Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens LCC:Diseases of the circulatory (Cardiovascular) system LCC:Surgery LCC:Medical emergencies. Critical care. Intensive care. First aid |
| مصطلحات موضوعية: | myocardial infarction, percutaneous transluminal coronary angioplasty, tpcs therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Diseases of the circulatory (Cardiovascular) system, RC666-701, Surgery, RD1-811, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9 |
| الوصف: | Objective: To study the effect of transcranial pulsed current stimulation (tPCS) therapy on cardiac arrhythmias developed after percutaneous transluminal coronary angioplasty (PTCA) with stenting in patients with myocardial infarction (MI).Material and methods: Characteristics of patient groups: the comparison group (n = 17) – with myocardial infarction, after PTCA with stenting, standard treatment; the main group (n = 21) – the same and tPCS therapy. Control points of the study: 1st day – Electrocardiography (ECG), Echocardiography (ECHO), Creatine phosphokinase (CPK), Creatine phosphokinase-MB (CPK-MB), Troponin-I, potassium, β-endorphin; 5th day – the same without ECHO; 10th day – the same and ECG with the determination of harmony and quantum of the electromagnetic flux of the cardiac cycle. PTCA was performed using drug-eluting stents. tPCS therapy was performed in pulsed bipolar mode, current strength 2 mA, current frequency 77.5 Hz, session duration 45 min.Results: In patients of the main group (against the background of tPCS therapy), the studied parameters of the cardiac cycle approached the optimal values. It was shown that intergroup differences in harmony (p = 0.002) and the size of the electromagnetic flux quantum of the cardiac cycle (p = 0.001) are statistically significant. Also, against the background of the tPCS therapy, the concentration of highly sensitive troponin-I is statistically significantly (p = 0.0042) lower by 109%. On the 5th and 10th days of the study, the serum concentration of β-endorphin in the main group was higher by 38.3 and 35.0% than in the comparison group (p < 0.05).Conclusion: The results of the study clearly demonstrate the cardioprotective and antiarrhythmic potential of tPCS therapy in patients with myocardial infarction and cardiac arrhythmias after PTCA with stenting. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | Russian |
| تدمد: | 2541-9897 |
| العلاقة: | https://www.innovmedkub.ru/jour/article/view/570Test; https://doaj.org/toc/2541-9897Test |
| DOI: | 10.35401/2541-9897-2022-25-3-29-36 |
| الوصول الحر: | https://doaj.org/article/e4d084cea2f147b4aeb47bab7a3fc216Test |
| رقم الانضمام: | edsdoj.4d084cea2f147b4aeb47bab7a3fc216 |
| قاعدة البيانات: | Directory of Open Access Journals |
| تدمد: | 25419897 |
|---|---|
| DOI: | 10.35401/2541-9897-2022-25-3-29-36 |